Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Vaccinia infection interferes with the presentation of influenza Haemagglutinin (HA) and Nucleoprotein (NP) to class I-restricted CTL. The inhibitory effect is selective for certain epitopes, and is more profound during the late phase of infection. For influenza A/NT/60/68 NP, the block is present during both early and late phases of infection, and is selective for the COOH-terminal epitope defined by peptide 366-379, having no detectable effect on the presentation of the NH2-terminal epitope 50-63. The presentation of HA is inhibited only during the late phase of vaccinia infection. For both proteins, presentation is partially (NP) or completely (HA) restored by expression of rapidly degraded protein fragments in the vaccinia infected target cell. For HA, deletion of the NH2-terminal signal sequence completely overcomes the block. For NP, either a large NH2-terminal deletion or the construction of a rapidly degraded ubiquitin-NP fusion protein partially restores presentation. These results illustrate the relationship between degradation of viral proteins in the cytoplasm of an infected cell and recognition of epitopes at the cell surface by class I-restricted T cells.

Original publication

DOI

10.1084/jem.168.4.1211

Type

Journal article

Journal

J Exp Med

Publication Date

01/10/1988

Volume

168

Pages

1211 - 1224

Keywords

Animals, Cells, Cultured, Epitopes, Female, Genetic Vectors, Hemagglutinins, Viral, Histocompatibility Antigens Class I, Mice, Mice, Inbred C57BL, Mice, Inbred CBA, Nucleoproteins, Orthomyxoviridae, Peptide Fragments, Precipitin Tests, Promoter Regions, Genetic, Protein Sorting Signals, Recombinant Fusion Proteins, Recombinant Proteins, T-Lymphocytes, Cytotoxic, Vaccinia virus